J. Safra Sarasin Holding Ag Madrigal Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.76 Trillion
- Q3 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 5,600 shares of MDGL stock, worth $1.89 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,600
Previous 5,751
2.63%
Holding current value
$1.89 Million
Previous $1.61 Billion
26.24%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
294Shares Held
21.9MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$838 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$691 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$686 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$674 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$668 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.79B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...